School owner gets death penalty for fatally beating one of his students
27-year old Natthaphol Thavornpibul, the owner of the Ban Phi Nath military cadet tutorial boarding school in Nakhon Sawan province,…
COVID-19 – Cargo Entry Point Update, 7 May 2020
In an effort to have an overview of the impact of COVID-19 on Humanitarian Supply Chains in the world, the…
Coronavirus disease 2019 (COVID-19) WHO Thailand Situation Report – 4 May 2020
SPOTLIGHT • Zero deaths reported today. • All 18 new cases reported today were detected in migrants entering the country…
COVID-19 Response: IOM Regional Office for Asia Pacific Situation Report 7 – May 4, 2020
OVERVIEW Reported COVID-19 cases in Asia and the Pacific continue to increase, though at a relatively stable pace, with countries…
Neuralstem’s NSI-566 stem cell therapy confers neurological improvement in spinal cord injury patients with complete paraplegia
– Neuralstem Announces Publication of Data From First-In-Human Study of Human Neural Stem Cell Transplantation for Chronic Spinal Cord Injury…
Six Mekong nations call for accelerated action to eliminate malaria before 2030
Geneva, May 23, 2018 (GLOBE NEWSWIRE) — The governments of Cambodia, China, the Lao People’s Democratic Republic, Myanmar, Thailand and…
Neuralstem Announces Publication of Long-Term Follow-up Data on ALS in the Annals of Clinical and Translational Neurology
Post-hoc comparison of combined cohorts from Phase 1 and 2 trials vs. historical controls revealed statistically significant difference in scores…
Best in Class Erectile Dysfunction Drug – DRGT announces dose escalation study results of its Super-Tadalafil DRGT-99
MALTA, May 02, 2018 (GLOBE NEWSWIRE) — DRGT, a specialty pharmaceutical company with a proprietary formulation technology, announced the results…
AstraZeneca Presents Imfinzi (durvalumab) Plus tremelimumab Combination Data at AACR Annual Meeting
Phase Ib Study 006 long-term follow-up shows clinical activity in PD-L1 ≥25% and <25% groups in 2nd-line non-small cell lung…
Neuralstem to Present Clinical Update at the Alliance for Regenerative Medicine 6th Annual Cell & Gene Therapy Investor Day
GERMANTOWN, Md., April 11, 2018 (GLOBE NEWSWIRE) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system…